About
Minimally invasive, implantable device for Benign Prostatic Hyperplasia
Areas of Focus
Categories
Medical Implant
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
397
By Phase
NA: 3
By Status
ACTIVE_NOT_RECRUITING: 1RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05341661Lead Sponsor
Butterfly Pivotal Study
NAActive, not recruiting
245 participants
Started: Apr 7, 2022 · Completed: Dec 31, 2029
NCT05330520Lead Sponsor
Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)
NARecruiting
60 participants
Started: Feb 10, 2021 · Completed: Feb 1, 2027
NCT03912558Lead Sponsor
Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients.
NACompleted
92 participants
Started: Oct 29, 2018 · Completed: Apr 1, 2024
Locations (1)
Headquarters
Yokneam, Israel
Map
Loading map...